Cite
MLA Citation
Mary Hughes et al.. “Accurate accounting of caplacizumab cost effectiveness – Authors' reply.” Lancet, vol. 8, no. 5, 2021, pp. e316–. http://access.bl.uk/ark:/81055/vdc_100129512045.0x000005
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mary Hughes et al.. “Accurate accounting of caplacizumab cost effectiveness – Authors' reply.” Lancet, vol. 8, no. 5, 2021, pp. e316–. http://access.bl.uk/ark:/81055/vdc_100129512045.0x000005